Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study

Figure 1

Study profile regarding apatinib plus PD-1 inhibitors for patients with previously treated advanced gastric cancer.